North America Leads the Industry; Post-operative Pain Management Market Outlook Report Unleashes the Forecast for 2023 -

Post-Operative Pain Management Market Size is projected to grow to USD 4.59 billion by 2030, exhibiting a (CAGR) of 6.8% during the forecast period (2023 - 2030)

Post-Operative Pain Management Market Overview:

Post-Operative Pain Management Market insights report has valued the industry size at USD 2.9 billion in 2022 and is projected to grow from USD 3.09 Billion in 2023 to USD 4.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8% during the forecast period (2023 - 2030).

Patient’s comfort is of the utmost priority in the healthcare sector, and post-operative pain management has a significant role to play in it. Pain is an unavoidable result in a post-operative scenario due to tissue injury and muscle spasm which can be treated with proper medication. The global post-operative pain management market is thriving on this. With an intent to mobilize the patient at the earliest and resume their ability to breathe and eat, physicians introduce these post-operative drugs. The demand for drugs and devices to treat such cases are on the rise as healthcare is now permeating to a wider patient pool. This has increased the number of surgeries where the requirement for such devices is obvious.

Furthermore, age becomes a complication as the reception of drugs in such cases differ from any normal patients which opens up scope for new drugs and research. The report has its finger on segmental analysis and factors that can be of great importance for the market in the coming years.  

On the flipside, these drugs often become a habit and overdose of it can cause fatal damage. This can be a daunting threat to the post-operative pain management market. As per the Centre for Disease Control and Prevention, the last decade has already witnessed a steep rise in the number of deaths caused by such overdoses.

Segmentation:

The global post-operative pain management market can be segmented by pain type, product, application, and target area.

Based on the pain type, the post-operative pain management market can be segmented into acute pain, moderate pain, and severe pain.

On the basis of product, the post-operative pain management market includes non-steroidal anti-inflammatory drugs (NSAIDs), antiepileptic drugs, COX-2 inhibitors, opioids, and other analgesics.

Application-wise, the post-operative pain management market comprises cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine, and others.

Based on target area, the post-operative pain management market comprises back, legs, hand, arms and other.

Regional Analysis:

Geographically, the global post-operative pain management market includes the Americas, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA).

The Americas is having a great run in the global post-operative pain management market due to the large patient pool availing treatment and surgical procedures. Superlative healthcare infrastructure is also impacting the market significantly in this region.

Europe accounts for the second largest revenue share owing to the increasing research and development (R&D) activities for the introduction of new drugs with fewer side-effects. Both private and public sectors are investing significant sums for R & D which is pushing the market forward.

The APAC is set for the fastest growth during the forecast period. The huge patient pool is expected to provide traction to the market. The post-operative pain management market in the MEA is projecting steady growth. However, lack of awareness and poor primary health care services in the underdeveloped areas of this region are posing great threats to the market.

Post-Operative Pain Management Market Competitive Analysis:

The prominent players highlighted in the post-operative pain management market outlook report are Johnson & Johnson (the U.S.), Purdue Pharma (the U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer (the U.S.), Eli Lilly (the U.S.), Endo Pharmaceuticals Plc. (the U.S.), Forest Laboratories Inc. (the U.S.), GlaxoSmithKline Plc. (the U.K.), Baxter International Inc. (the U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Valeant Pharmaceuticals International Inc. (Canada), and others.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com


Rahul Yash

110 Blog posts

Comments